PubRank

R W Carrell

Author PubWeight™ 181.11‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 The mechanism of Z alpha 1-antitrypsin accumulation in the liver. Nature 1992 5.71
2 The serpins are an expanding superfamily of structurally similar but functionally diverse proteins. Evolution, mechanism of inhibition, novel functions, and a revised nomenclature. J Biol Chem 2001 4.81
3 Structure and variation of human alpha 1-antitrypsin. Nature 1982 4.13
4 Structure of a serpin-protease complex shows inhibition by deformation. Nature 2000 4.02
5 Implications of the three-dimensional structure of alpha 1-antitrypsin for structure and function of serpins. Biochemistry 1989 3.18
6 The anticoagulant activation of antithrombin by heparin. Proc Natl Acad Sci U S A 1997 3.09
7 The estimation of red cell superoxide dismutase activity. J Lab Clin Med 1975 2.75
8 Mutation of antitrypsin to antithrombin. alpha 1-antitrypsin Pittsburgh (358 Met leads to Arg), a fatal bleeding disorder. N Engl J Med 1983 2.36
9 What do dysfunctional serpins tell us about molecular mobility and disease? Nat Struct Biol 1995 2.30
10 Variations in the structure of human haemoglobin. With particular reference to the unstable haemoglobins. Br Med Bull 1969 2.07
11 Smoking, lung function, and alpha 1-antitrypsin deficiency. Lancet 1985 1.99
12 Familial dementia caused by polymerization of mutant neuroserpin. Nature 1999 1.88
13 A simple method for the detection of unstable haemoglobins. Br J Haematol 1972 1.87
14 Reactions involving superoxide and normal and unstable haemoglobins. Biochem J 1976 1.66
15 Inhibitory conformation of the reactive loop of alpha 1-antitrypsin. Nat Struct Biol 1996 1.66
16 alpha 1-Antitrypsin: molecular pathology, leukocytes, and tissue damage. J Clin Invest 1986 1.61
17 Inactive conformation of the serpin alpha(1)-antichymotrypsin indicates two-stage insertion of the reactive loop: implications for inhibitory function and conformational disease. Proc Natl Acad Sci U S A 2000 1.54
18 A circulating variant of human proalbumin. Nature 1978 1.52
19 Crystal structure of uncleaved ovalbumin at 1.95 A resolution. J Mol Biol 1991 1.52
20 Effect of the Z mutation on the physical and inhibitory properties of alpha 1-antitrypsin. Biochemistry 1993 1.49
21 Hormone binding globulins undergo serpin conformational change in inflammation. Nature 1988 1.47
22 Abnormal haem binding and globin SH group blockade in unstable haemoglobins. Nature 1968 1.44
23 Plakalbumin, alpha 1-antitrypsin, antithrombin and the mechanism of inflammatory thrombosis. Nature 1985 1.44
24 Crystal structure of ovalbumin as a model for the reactive centre of serpins. Nature 1990 1.42
25 Alpha 1-antitrypsin Siiyama (Ser53-->Phe). Further evidence for intracellular loop-sheet polymerization. J Biol Chem 1993 1.41
26 Activated oxygen and haemolysis. Br J Haematol 1975 1.41
27 A new hemoglobin variant resembling hemoglobin E. Hemoglobin E Saskatoon: beta-22 Glu replaced by Lys. Can J Biochem 1967 1.40
28 The active conformation of plasminogen activator inhibitor 1, a target for drugs to control fibrinolysis and cell adhesion. Structure 1999 1.40
29 Studies of hemoglobin denaturation and Heinz body formation in the unstable hemoglobins. J Clin Invest 1974 1.39
30 Imprisonment of J-P Allain. Lancet 1993 1.34
31 Haemoglobin Köln (beta-98 valine--methionine): an unstable protein causing inclusion-body anaemia. Nature 1966 1.33
32 alpha 1-Antitrypsin Mmalton (Phe52-deleted) forms loop-sheet polymers in vivo. Evidence for the C sheet mechanism of polymerization. J Biol Chem 1995 1.33
33 Differences between alpha- and beta-chain mutants of human haemoglobin and between alpha- and beta-thalassaemia. Possible duplication of the alpha-chain gene. Br Med J 1968 1.33
34 Effects of mutations in the hinge region of serpins. Biochemistry 1993 1.29
35 The unstable haemoglobin haemolytic anaemias. Semin Hematol 1969 1.27
36 The 2.6 A structure of antithrombin indicates a conformational change at the heparin binding site. J Mol Biol 1997 1.27
37 A 2.6 A structure of a serpin polymer and implications for conformational disease. J Mol Biol 1999 1.26
38 Structural and functional characterization of the abnormal Z alpha 1-antitrypsin isolated from human liver. FEBS Lett 1984 1.24
39 Oxidation of human haemoglobin by copper. Mechanism and suggested role of the thiol group of residue beta-93. Biochem J 1977 1.22
40 The serpin inhibitory mechanism is critically dependent on the length of the reactive center loop. J Biol Chem 2001 1.22
41 The significance of monoclonal gammopathy in a normal population. Aust N Z J Med 1971 1.16
42 Basis of the defect in alpha-1-antitrypsin deficiency. Nature 1973 1.16
43 Preparation and characterization of latent alpha 1-antitrypsin. J Biol Chem 1995 1.15
44 Thromboembolic disease due to thermolabile conformational changes of antithrombin Rouen-VI (187 Asn-->Asp) J Clin Invest 1994 1.14
45 Prevalence of antithrombin deficiency in the healthy population. Br J Haematol 1994 1.13
46 Yeast KEX2 protease has the properties of a human proalbumin converting enzyme. Science 1987 1.13
47 A new doubly substituted sickling haemoglobin: HbS-Oman. Br J Haematol 1989 1.12
48 Conformational changes in serpins: II. The mechanism of activation of antithrombin by heparin. J Mol Biol 2000 1.12
49 The amino acid sequence of the alpha chain of the major haemoglobin of the rat (Rattus norvegicus). Biochem J 1975 1.11
50 alpha 1-Antitrypsin microheterogeneity. Isolation and physiological significance of isoforms. Biochim Biophys Acta 1982 1.10
51 Mechanism of oxyhaemoglobin breakdown on reaction with acetylphenylhydrazine. Biochem J 1978 1.06
52 Inhibition of plasmin, urokinase, tissue plasminogen activator, and C1S by a myxoma virus serine proteinase inhibitor. J Biol Chem 1993 1.06
53 Dysfunctional C1-inhibitor(At), isolated from a type II hereditary-angio-oedema plasma, contains a P1 'reactive centre' (Arg444----His) mutation. Biochem J 1988 1.06
54 Alpha-1-antitrypsin-Pittsburgh. A potent inhibitor of human plasma factor XIa, kallikrein, and factor XIIf. J Clin Invest 1986 1.05
55 Antithrombins Wibble and Wobble (T85M/K): archetypal conformational diseases with in vivo latent-transition, thrombosis, and heparin activation. Blood 1998 1.04
56 Structural explanation for the deficiency of S alpha 1-antitrypsin. Nat Struct Biol 1996 1.04
57 Implications for function and therapy of a 2.9 A structure of binary-complexed antithrombin. J Mol Biol 1998 1.03
58 The conformational activation of antithrombin. A 2.85-A structure of a fluorescein derivative reveals an electrostatic link between the hinge and heparin binding regions. J Biol Chem 2000 1.03
59 Importance of the release of strand 1C to the polymerization mechanism of inhibitory serpins. Protein Sci 1997 1.03
60 Human alpha 1-antitrypsin: carbohydrate attachment and sequence homology. FEBS Lett 1981 1.02
61 Polymerization of plasminogen activator inhibitor-1. J Biol Chem 2000 1.00
62 Latent antithrombin and its detection, formation and turnover in the circulation. J Thromb Haemost 2004 1.00
63 Heparin-dependent modification of the reactive center arginine of antithrombin and consequent increase in heparin binding affinity. J Biol Chem 1997 1.00
64 Conformational changes in serpins: I. The native and cleaved conformations of alpha(1)-antitrypsin. J Mol Biol 2000 1.00
65 Functional abnormality of proalbumin Christchurch. Biochim Biophys Acta 1980 1.00
66 Hydrolink gels: a rapid and simple approach to the detection of DNA mutations in thromboembolic disease. J Clin Pathol 1992 1.00
67 The structural basis for neutrophil inactivation of C1 inhibitor. Biochem J 1989 0.99
68 A genetically engineered mutant of alpha 1-antitrypsin protects connective tissue from neutrophil damage and may be useful in lung disease. Lancet 1984 0.98
69 Ovalbumin and angiotensinogen lack serpin S-R conformational change. Biochem J 1989 0.98
70 Haemoglobin sydney: Beta-67 (E11) valine modified to alanine: an emerging pattern of unstable haemoglobins. Nature 1967 0.98
71 Increased proteolytic cleavage of alpha 1-antitrypsin (alpha 1-proteinase inhibitor) in knee-joint synovial fluid from patients with rheumatoid arthritis. Biochem Soc Trans 1990 0.98
72 The control of neutrophil chemotaxis by inhibitors of cathepsin G and chymotrypsin. J Biol Chem 1995 0.98
73 Heparin binding defect in a new antithrombin III variant: Rouen, 47 Arg to His. Blood 1987 0.97
74 Formation of the antithrombin heterodimer in vivo and the onset of thrombosis. Blood 1999 0.97
75 Mutations which impede loop/sheet polymerization enhance the secretion of human alpha 1-antitrypsin deficiency variants. J Biol Chem 1995 0.95
76 Probing serpin reactive-loop conformations by proteolytic cleavage. Biochem J 1996 0.95
77 Protein C deficiency and portal thrombosis in liver transplantation in children. Lancet 1988 0.95
78 Haemoglobin Genova: beta-28 (B10) leucine replaced by proline. Nature 1967 0.95
79 Three cysteine residues in the alpha chain of rat haemoglobin (albino Rattus norvegicus): 13 (A 11), 104 (G 11) and 111 (G 18). Biochim Biophys Acta 1974 0.94
80 The effect of the Z mutation on the ability of alpha 1-antitrypsin to prevent neutrophil mediated tissue damage. Biochim Biophys Acta 1994 0.93
81 Translation and processing of normal (PiMM) and abnormal (PiZZ) human alpha 1-antitrypsin. FEBS Lett 1983 0.92
82 Haemoglobin J Tongariki (alpha-115 alanine--aspartic acid): the first new haemoglobin variant found in a Pacific (Melanesian) population. J Med Genet 1967 0.91
83 Köln haemoglobinopathy. Further data and a comparison with other hereditary Heinz body anaemias. Br J Haematol 1967 0.91
84 Apolipoprotein E2-Christchurch (136 Arg----Ser). New variant of human apolipoprotein E in a patient with type III hyperlipoproteinemia. J Clin Invest 1987 0.91
85 Antithrombin Glasgow, 393 Arg to His: a P1 reactive site variant with increased heparin affinity but no thrombin inhibitory activity. FEBS Lett 1988 0.91
86 Mutations in the shutter region of antithrombin result in formation of disulfide-linked dimers and severe venous thrombosis. J Thromb Haemost 2004 0.90
87 The effect of a reducing-end extension on pentasaccharide binding by antithrombin. J Biol Chem 2000 0.90
88 Conformational changes in serpins: I. The native and cleaved conformations of alpha(1)-antitrypsin. J Mol Biol 2000 0.90
89 Kinetic studies on the interaction of alpha 1-proteinase inhibitor (Pittsburgh) with trypsin-like serine proteinases. Biol Chem Hoppe Seyler 1986 0.89
90 Proteolysis of human native and oxidised alpha 1-proteinase inhibitor by matrilysin and stromelysin. Biochim Biophys Acta 1994 0.89
91 Active site of alpha 1-antitrypsin: homologous site in antithrombin-III. Biochem Biophys Res Commun 1980 0.88
92 New carbohydrate site in mutant antithrombin (7 Ile----Asn) with decreased heparin affinity. FEBS Lett 1988 0.88
93 Proposed heparin binding site in antithrombin based on arginine 47. A new variant Rouen-II, 47 Arg to Ser. J Clin Invest 1988 0.88
94 Preparative induction and characterization of L-antithrombin: a structural homologue of latent plasminogen activator inhibitor-1. Biochemistry 1997 0.88
95 Detection of variants of haemoglobin D in Australia: haemoglobin D Camperdown alpha 2 A beta 2 121 Glu leads to Val and haemoglobin D Punjab alpha 2 A beta 2 121 Glu leads to Gin. Med J Aust 1974 0.88
96 Alzheimer's disease. Enter a protease inhibitor. Nature 1988 0.87
97 Alpha-1-antitrypsin variants in New Zealand. N Z Med J 1975 0.87
98 Angiotensinogen cleavage by renin: importance of a structurally constrained N-terminus. FEBS Lett 1998 0.87
99 Development of a novel recombinant serpin with potential antithrombotic properties. J Biol Chem 1995 0.87
100 Molecular genetics of human antithrombin deficiency. Hum Mutat 1996 0.86
101 The serpins: nature's molecular mousetraps. Sci Prog 2001 0.86
102 The attachment of Heinz bodies to the red cell membrane. Br J Haematol 1973 0.86
103 Circulating proalbumin associated with a variant proteinase inhibitor. Biochim Biophys Acta 1984 0.85
104 alpha-1-Antitrypsin: sequence of the Z variant tryptic peptide. FEBS Lett 1977 0.85
105 Mechanisms of antithrombin polymerisation and heparin activation probed by the insertion of synthetic reactive loop peptides. Biol Chem 1997 0.85
106 In vitro synthesis of M and Z forms of human alpha 1-antitrypsin. FEBS Lett 1982 0.84
107 Proteolytic inactivation of human alpha 1 antitrypsin by human stromelysin. FEBS Lett 1991 0.84
108 Antithrombin Rouen-IV 24 Arg----Cys. The amino-terminal contribution to heparin binding. FEBS Lett 1990 0.84
109 Protease specificity and heparin binding and activation of recombinant protease nexin I. J Biol Chem 1991 0.83
110 A protein structural approach to the solution of biological problems: alpha 1-antitrypsin as a recent example. Am J Physiol 1993 0.83
111 Oxidative interactions between haemoglobin and membrane lipid. A liposome model. Biochem J 1984 0.83
112 CpG dinucleotides are "hotspots" for mutation in the antithrombin III gene. Twelve variants identified using the polymerase chain reaction. Mol Biol Med 1989 0.83
113 Characterization of the alpha chain core of human haemoglobin variants. Biochim Biophys Acta 1968 0.83
114 alpha 1-Antitrypsin Christchurch, 363 Glu----Lys: mutation at the P'5 position does not affect inhibitory activity. Biochim Biophys Acta 1986 0.83
115 Genetic engineering and the serpins. Bioessays 1988 0.82
116 Antithrombin Dublin (-3 Val----Glu): an N-terminal variant which has an aberrant signal peptidase cleavage site. FEBS Lett 1990 0.82
117 Bassen-Kornzweig and Refsum's syndromes. Some comments on their recognition among the N.Z. population. N Z Med J 1966 0.82
118 The incidence of dysfunctional antithrombin variants: four cases in 210 patients with thromboembolic disease. Br J Haematol 1991 0.82
119 Characterization of Heinz bodies in unstable haemoglobin haemolytic anaemia. Nature 1972 0.81
120 The abnormality of the S variant of human alpha-1-antitrypsin. Biochim Biophys Acta 1976 0.81
121 Haemoglobin Camperdown beta104(G6) arginine leads to serine. Biochim Biophys Acta 1975 0.81
122 Recombinant antitrypsin Pittsburgh undergoes proteolytic cleavage during E. coli sepsis and fails to prevent the associated coagulopathy in a primate model. Thromb Haemost 1998 0.81
123 Commercial plasma alpha1-antitrypsin (Prolastin) contains a conformationally inactive, latent component. Eur Respir J 1997 0.80
124 The reactive site of alpha 1-antitrypsin is C-terminal, not N-terminal. Biochim Biophys Acta 1983 0.80
125 Hemoglobin Brisbane: beta68 Leu replaced by His. A new high oxygen affinity variant. Hemoglobin 1981 0.80
126 Hemoglobin Palmerston North beta 23 (B5) Val replaced by Phe. A new variant identified in a patient with polycythemia. Hemoglobin 1982 0.79
127 Haemoglobin F auckland G gamma 7 Asp leads to Asn: further evidence for multiple genes for the gamma chain. Biochim Biophys Acta 1974 0.79
128 Alpha-1-antitrypsin deficiency in New Zealand. N Z Med J 1975 0.79
129 Zinc acetate as a precipitant of unstable haemoglobins. J Clin Pathol 1981 0.79
130 Haemoglobin F Melbourne Ggamma 16 Gly leads to Arg and haemoglobin F carlton Ggamma 121 Glu leads to Lys. Further evidence for varied activity of gamma-chain genes. Biochim Biophys Acta 1977 0.79
131 Alpha 1-antitrypsin, emphysema and smoking. N Z Med J 1984 0.79
132 Retracted Heparin binding site, conformational change, and activation of antithrombin. Biochemistry 1992 0.79
133 Human alpha 1-antitrypsin expression in Xenopus oocytes. Secretion of the normal (PiM) and abnormal (PiZ) forms. Eur J Biochem 1985 0.79
134 Human Z alpha 1-antitrypsin accumulates intracellularly and stimulates lysosomal activity when synthesised in the Xenopus oocyte. FEBS Lett 1985 0.79
135 The molecular pathology of human alpha 1-antitrypsin. Biochem Soc Symp 1984 0.78
136 The precipitation of hemoglobin by zinc: its application to the isolation of a minor hemoglobin fraction (HbB2 delta 16 Gly replaced by Arg) from lysed whole blood. Hemoglobin 1982 0.78
137 Alpha 1-antitrypsin and serum albumin mRNA accumulation in normal, acute phase and ZZ human liver. FEBS Lett 1985 0.78
138 Characterization of Hb Aalborg, a new unstable hemoglobin variant, by fast atom bombardment mass spectrometry. Hemoglobin 1990 0.78
139 Detecting iron deficiency by serum tests. Clin Chem 1985 0.78
140 Two novel antithrombin variants, Asn187Asp and Asn187Lys, indicate a functional role for asparagine 187. Blood Coagul Fibrinolysis 1995 0.78
141 A pilot study of antithrombin replacement in intensive care management: the effects on mortality, coagulation and renal function. Transfus Med 1991 0.78
142 Characterization of antithrombins produced by active site mutagenesis of human alpha 1-antitrypsin expressed in yeast. Blood 1989 0.78
143 Serpins: implications of a mobile reactive centre. Curr Opin Biotechnol 1992 0.78
144 Heterozygous alpha 1-antitrypsin deficiency: a longitudinal lung function study. N Z Med J 1981 0.77
145 Five antithrombin variants, four associated with thrombosis. Blood Coagul Fibrinolysis 1997 0.77
146 Haemoglobin M Hyde Park: a hereditary methaemoglobinaemia in a Caucasian child. N Z Med J 1968 0.77
147 Screening for heparin binding variants of antithrombin. J Clin Pathol 1991 0.77
148 Antithrombin Cambridge, 384 Ala to Pro: a new variant identified using the polymerase chain reaction. FEBS Lett 1989 0.77
149 Insertions/deletions in the antithrombin gene: 3 mutations associated with non-expression. Thromb Haemost 1992 0.77
150 Intracellular serpins in haemopoietic and peripheral blood cells. Br J Haematol 2001 0.77
151 Antithrombin cambridge II (Ala384Ser): clinical, functional and haplotype analysis of 18 families. Thromb Haemost 1998 0.76
152 Antithrombin Cambridge II, 384 Ala to Ser. Further evidence of the role of the reactive centre loop in the inhibitory function of the serpins. FEBS Lett 1991 0.76
153 Ligand-binding properties of proalbumin Christchurch. Biochem J 1980 0.75
154 Heparin binding site, conformational change, and activation of antithrombin. Biochemistry 1995 0.75
155 A tale of two proteinases. Nat Struct Biol 1994 0.75
156 Homozygous cystinuria and the oculo-cerebro-renal dystrophy of Lowe in same family. Arch Dis Child 1976 0.75
157 Recombinant natural anticoagulants: a review. J R Soc Med 1992 0.75
158 The isolation and identification of haemoglobin Lephore Boston (Washington) in an Australian family. Med J Aust 1975 0.75
159 Hemoglobinopathies in Oceania. Hemoglobin 1980 0.75
160 The absence of lipid peroxidation in human red cells exposed to acetylphenylhydrazine. Br J Haematol 1972 0.75
161 HbA2 Victoria delta 24 (B6) Gly----Asp. A new delta chain variant occurring with beta-thalassemia. Hemoglobin 1984 0.75
162 Type I antithrombin deficiency: five novel mutations associated with thrombosis. Blood Coagul Fibrinolysis 1996 0.75
163 Isolation of high oxygen affinity hemoglobins. Hemoglobin 1977 0.75
164 Precipitation of hemoglobin by zinc: the detection and isolation of unstable hemoglobins and the concentration of dilute hemoglobin solutions. Prog Clin Biol Res 1981 0.75
165 A new approach to haemoglobin variant identification. Haemoglobin Christchurch beta-71 (E15) phenylalanine leads to serine. Biochim Biophys Acta 1971 0.75
166 Hb Brisbane (beta 68 (E12) Leu replaced by His) is unstable. Hemoglobin 1983 0.75
167 Hemoglobin Collingwood beta 60 (E4) Val replaced by Ala. A new unstable hemoglobin. Hemoglobin 1983 0.75
168 Alpha-1-Antitrysin: structural relationships of the substitutions of the S and Z variants. FEBS Lett 1978 0.75
169 Obesity in a New Zealand community. N Z Med J 1975 0.75
170 A new hybrid haemoglobin: haemoglobin Strumica/Beograd occurring in an individual with four haemoglobins. Pathology 1977 0.75
171 A novel member of the serpin superfamily is encoded on a circular plasmid-like DNA species isolated from rabbit cells. FEBS Lett 1986 0.75
172 Hypoglycaemic effect of pentamidine detected by glucose screen. Lancet 1977 0.75
173 Two unstable hemoglobins in one individual: Hb Atlanta (beta 75 Leu leads to Pro) and Hb Coventry (beta 141 Leu deleted). Hemoglobin 1983 0.75
174 Two de novo mutations in one beta globin chain: hemoglobin Atlanta-Coventry, beta 75 Leu----Pro and beta 141 Leu deleted. Hemoglobin 1986 0.75
175 Alpha 1-antitrypsin-Pittsburgh: a potent inhibitor of human plasma factor XIa, kallikrein, and factor XIIf. Trans Assoc Am Physicians 1985 0.75
176 Hemoglobin autoxidation: the risk of the red cell and the contribution of copper. Prog Clin Biol Res 1978 0.75
177 Unstable haemoglobin haemolytic crises: contributions of pyrexia and neutrophil oxidants. Br J Haematol 1981 0.75
178 Hemoglobin A2 Fitzroy delta 142 Ala----Asp: a new delta-chain variant. Hemoglobin 1984 0.75
179 Polycythaemia associated with a new haemoglobin variant: haemoglobin Palmerston North beta 23 (B5) val----phe. N Z Med J 1985 0.75
180 Effect of alanine insertion (P'5) on the reactive centre of alpha 1-antitrypsin. FEBS Lett 1991 0.75
181 Contributions of other sterols to the estimation of cholesterol. Clin Chim Acta 1976 0.75
182 Molecular characterization of antithrombin Barcelona-2: 47 arginine to cysteine. Thromb Res 1989 0.75
183 Detection of abnormal haemoglobins by the Technicon H6000 automated cell counter. Br J Haematol 1985 0.75
184 Two antithrombin mutations in a compound heterozygote: Met20Thr and Tyr166Cys. Am J Hematol 1995 0.75
185 Monoclonal gammopathy: study of 52 cases. N Z Med J 1970 0.75
186 [Structure analysis of hemoglobin Köln]. Klin Wochenschr 1967 0.75
187 Reactivity of the beta-93 SH groups in Hb Köln. Hemoglobin 1977 0.75
188 Routine serum lipid analysis in New Zealand. N Z Med J 1978 0.75
189 The unstable hemoglobins. Tex Rep Biol Med 1982 0.75
190 Hemoglobin Summer Hill beta 52(D3) Asp leads to His a new variant from Sydney, Australia. Hemoglobin 1980 0.75
191 Rapid proteolysis of unstable globins in human bone marrow. Br J Haematol 1983 0.75
192 Hemoglobin Volga, beta 27 (B9) Ala replaced by Asp: functional and clinical correlations of an unstable hemoglobin. Hemoglobin 1980 0.75
193 Nomenclature of the alpha-thalassaemias. Lancet 1984 0.75
194 The assessment of serum amino acids. N Z Med J 1970 0.75
195 The plasma turnover of transfused antithrombin concentrate in patients with acquired antithrombin deficiency. Transfus Med 1996 0.75
196 Coagulation changes following hepatic revascularization during liver transplantation. Transplantation 1989 0.75
197 Haemoglobin--a frustrated oxidase? Implications for red cell metabolism. Hemoglobin 1977 0.75
198 Reactive-centre variants of alpha 1-antitrypsin. A new range of anti-inflammatory agents. Biotechnol Genet Eng Rev 1986 0.75